Studies using AUC to examine appropriateness of percutaneous coronary intervention (PCI) have been directed at identifying perceived PCI overuse via suspected methods, while largely ignoring clear ...

(European Heart Journal) A Japanese trial failed to show significant clinical benefit for icosapent ethyl (Vascepa) in statin users with coronary artery disease and low eicosapentaenoic acid levels.